I-ATP citrate-lyase

CAT # Igama lemveliso Inkcazo
CPD3611 SB-204990 I-SB-204990 yiprodrug ye-ATP enamandla ye-citrate-lyase inhibitor SB-201076. I-SB-204990, xa ilawulwa ngomlomo kwiigundane, ifakwe kwi-systemic circulation, i-pharmacologically related concentrations ye-SB-201076 yafunyanwa kwisibindi. I-SB-204990 (i-25 mg / kg ngosuku) nayo yehla amanqanaba e-cholesterol e-plasma (ukuya kuthi ga kwi-23%) kunye namanqanaba e-triglyceride (ukuya kuthi ga kwi-38%) kwinja, ngokukhetha ukunciphisa i-low-density lipoprotein xa kuthelekiswa ne-high-density lipoprotein cholesterol. amanqanaba. I-SB-204990 yi-enzyme ebalulekileyo ekulawuleni ukunikezelwa kwe-substrate ye-lipid synthesis de novo kunye nethagethi ye-enzyme enokwenzeka yokungenelela kwe-hypolipidaemic.

Qhagamshelana nathi

Ukubuza

Iindaba zamva

  • Iindlela eziPhezulu ze-7 kuPhando lwezoPhando kwi-2018

    IiNdlela ezi-7 eziphambili kuPhando lwaMayeza...

    Ukuba phantsi koxinzelelo oluhlala lukhula lokukhuphisana kwimeko yezoqoqosho kunye nethekhinoloji ecela umngeni, iinkampani zamayeza kunye nebhayoloji kufuneka ziqhubeke zenza izinto ezintsha kwiinkqubo zazo zeR&D ukuze zihlale phambili ...

  • I-ARS-1620: I-inhibitor entsha ethembisayo ye-KRAS-mutant cancers

    I-ARS-1620: Isithinteli esitsha esithembisayo se-K...

    Ngokophononongo olupapashwe kwiSeli, abaphandi baye baphuhlisa inhibitor ethile ye-KRASG12C ebizwa ngokuba yi-ARS-1602 ebangele ukuhlehla kwethumba kwiimpuku. "Olu phononongo lubonelela ngobungqina bokuba i-KRAS eguqukayo inokuba...

  • I-AstraZeneca ifumana unyuso lolawulo lwamachiza e-oncology

    I-AstraZeneca ifumana unyuso lolawulo lwe...

    I-AstraZeneca ifumene ukongezwa okuphindwe kabini kwipotfoliyo yayo ye-oncology ngoLwesibini, emva kokuba abalawuli base-US naseYurophu bamkele ukungeniswa kolawulo lwamachiza ayo, inyathelo lokuqala lokuphumelela ukuvunywa kwala mayeza. ...

Incoko ka-WhatsApp kwi-Intanethi!